applied to patients with preleukaemic conditions. The methods used here are as previously described.5 8
Case history
A 60 year old woman with Sweet's disease was referred for assessment to the haematology clinic in October 1983. She had had moderately severe rheumatoid arthritis (seronegative) for 10 years and was taking eight aspirin tablets daily. Sweet's disease confirmed by biopsy was diagnosed in September 1983 when she presented with nodular erythema of the upper arms, face, and legs. Though a similar rash had occurred intermittently over the preceding six years, fever was never documented. Clinically she was well, and peripheral blood findings were as follows: haemoglobin 7.7 g/dl, mean cell volume 68 fl, white cell count 10-9 x 109/l, neutrophils 46%, lymphocytes 41%, monocytes 13%, platelets 275 x 109/l. Erythrocyte sedimentation rate was 65 mm/first hour. There was no obvious source of blood loss, and faecal occult blood tests yielded negative results. The marrow aspirate was hypercellular due to myeloid hyperplasia, and myeloid maturation was normal. There was no monocytosis and no evidence of leukaemia or myelodysplastic syndrome. Erythropoiesis was micronormoblastic and iron stones were absent. Dual esterase staining showed more than 95% chloroacetate esterase positivity. Marrow leucocyte lysosomal enzyme profile was abnormal, with a pronounced increase in ,B-hexosaminidase activity, a slight rise in a-mannosidase activity, and a low B peak on isoelectric focusing of fi-hexosaminidase (table   and figure) . This pattern is similar to that seen in patients with acute myeloid leukaemia.' Trephine biopsy of the iliac crest showed reactive changes with 67 The monocytosis present on initial presentation in our patient suggests the existence of a myelodysplastic condition or early chronic myelomonocytic leukaemia, and the initial marrow showed myeloid hyperplasia with a lysosomal enzyme profile consistent with a myeloid abnormality.
The lysosomal enzyme patterns in patients with myelodysplasia and chronic myelomonocytic leukaemia have not been studied, but in view of their leukaemic potential and in the light of this case these studies might identify the high risk group early on. Interestingly, this laboratory has also detected an acute myeloid leukaemia type pattern of lysosomal enzymes in a patient with Hodgkin's disease who had been successfully treated with chemotherapy and radiotherapy some years before. He developed acute myeloid leukaemia 12 months later. This reinforces the suggestion that typical patterns of lysosomal enzyme abnormality can be helpful, not only in the classification of established leukaemias, but also in predicting leukaemic transformation in patients with primary and secondary myelodysplasias as well as in Sweet's disease.
